Extremely high-frequency electromagnetic radiation enhances neutrophil response to particulate agonists
Abstract
Extremely high-frequency electromagnetic radiation enhances neutrophil response to particulate agonists Vlasova II, Mikhalchik EV, Gusev AA, Balabushevich NG, Gusev SA, Kazarinov KD. Extremely high-frequency electromagnetic radiation enhances neutrophil response to particulate agonists. Bioelectromagnetics. 2017 Nov 30. doi: 10.1002/bem.22103. Abstract The growing use of extremely high-frequency electromagnetic radiation (EHF EMR) in information and communication technology and in biomedical applications has raised concerns regarding the potential biological impact of millimeter waves (MMWs). Here, we elucidated the effects of MMW radiation on neutrophil activation induced by opsonized zymosan or E. coli in whole blood ex vivo. After agonist addition to blood, two samples were prepared. A control sample was incubated at ambient conditions without any treatment, and a test sample was exposed to EHF EMR (32.9-39.6 GHz, 100 W/m2 ). We used methods that allowed us to assess the functional status of neutrophils immediately after exposure: oxidant production levels were measured by luminol-dependent chemiluminescence, and morphofunctional changes to neutrophils were observed in blood smears. Results revealed that the response of neutrophils to both agonists was intensified if blood was exposed to MMW radiation for 15 min. Neutrophils were intact in both the control and irradiated samples if no agonist was added to blood before incubation. Similarly, exposing suspensions of isolated neutrophils in plasma to MMW radiation. ncbi.nlm.nih.gov
AI evidence extraction
Main findings
In whole blood ex vivo, exposure to extremely high-frequency electromagnetic radiation (32.9–39.6 GHz; 100 W/m2) for 15 min intensified neutrophil responses to opsonized zymosan or E. coli, including increased oxidant production and morphofunctional changes. No apparent neutrophil damage was reported in control vs irradiated samples when no agonist was added before incubation.
Outcomes measured
- Neutrophil activation/functional status
- Oxidant production (luminol-dependent chemiluminescence)
- Morphofunctional changes in neutrophils (blood smears)
Limitations
- Ex vivo/in vitro design (whole blood and isolated neutrophil suspensions)
- not an in vivo health outcome study
- No sample size reported in the provided abstract/metadata
- Exposure described by frequency range and power density
- SAR not reported
View raw extracted JSON
{
"study_type": "in_vitro",
"exposure": {
"band": "mmWave",
"source": "other",
"frequency_mhz": null,
"sar_wkg": null,
"duration": "15 min"
},
"population": null,
"sample_size": null,
"outcomes": [
"Neutrophil activation/functional status",
"Oxidant production (luminol-dependent chemiluminescence)",
"Morphofunctional changes in neutrophils (blood smears)"
],
"main_findings": "In whole blood ex vivo, exposure to extremely high-frequency electromagnetic radiation (32.9–39.6 GHz; 100 W/m2) for 15 min intensified neutrophil responses to opsonized zymosan or E. coli, including increased oxidant production and morphofunctional changes. No apparent neutrophil damage was reported in control vs irradiated samples when no agonist was added before incubation.",
"effect_direction": "mixed",
"limitations": [
"Ex vivo/in vitro design (whole blood and isolated neutrophil suspensions), not an in vivo health outcome study",
"No sample size reported in the provided abstract/metadata",
"Exposure described by frequency range and power density; SAR not reported"
],
"evidence_strength": "low",
"confidence": 0.74,
"peer_reviewed_likely": "yes",
"keywords": [
"extremely high-frequency",
"millimeter waves",
"EHF EMR",
"32.9–39.6 GHz",
"100 W/m2",
"whole blood ex vivo",
"neutrophils",
"zymosan",
"E. coli",
"oxidant production",
"chemiluminescence"
],
"suggested_hubs": []
}AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.
NNEMF synthesis
Synthesis pending.